The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis B vaccine, Bexsero, for approval for use in patients aged 2 months or older.

Italy’s health ministry banned the sale of four flu drugs for possible side-effects while Switzerland’s regulator, Swissmedic, also suspended deliveries of Novartis’ flu vaccines as a ...

The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...

Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe. This content ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.